MX2009011208A - Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5. - Google Patents
Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5.Info
- Publication number
- MX2009011208A MX2009011208A MX2009011208A MX2009011208A MX2009011208A MX 2009011208 A MX2009011208 A MX 2009011208A MX 2009011208 A MX2009011208 A MX 2009011208A MX 2009011208 A MX2009011208 A MX 2009011208A MX 2009011208 A MX2009011208 A MX 2009011208A
- Authority
- MX
- Mexico
- Prior art keywords
- modulators
- acid derivatives
- nicotinic acid
- glutamate receptor
- metabotropic glutamate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
Abstract
The present invention relates to novel benzimidazole derivatives, their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them, wherein the compounds have the Formula (I): in which the substitutents are as defined in claim 1 and and salts, solvates, hydrates and N- oxides thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07106537 | 2007-04-19 | ||
PCT/EP2008/054682 WO2008128968A1 (en) | 2007-04-19 | 2008-04-17 | Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009011208A true MX2009011208A (en) | 2009-10-30 |
Family
ID=38654771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009011208A MX2009011208A (en) | 2007-04-19 | 2008-04-17 | Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20090105266A1 (en) |
EP (1) | EP2146969A1 (en) |
JP (1) | JP2010524892A (en) |
KR (1) | KR20090130141A (en) |
CN (1) | CN101679299A (en) |
AR (1) | AR068072A1 (en) |
AU (1) | AU2008240790A1 (en) |
BR (1) | BRPI0810653A2 (en) |
CA (1) | CA2682676A1 (en) |
CL (1) | CL2008001114A1 (en) |
EA (1) | EA200901379A1 (en) |
MX (1) | MX2009011208A (en) |
PE (1) | PE20090074A1 (en) |
TW (1) | TW200904425A (en) |
WO (1) | WO2008128968A1 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0606774D0 (en) * | 2006-04-03 | 2006-05-10 | Novartis Ag | Organic compounds |
WO2010135493A2 (en) * | 2009-05-20 | 2010-11-25 | Emory University | Alzheimer's disease imaging agents |
EP2390245A1 (en) * | 2010-05-26 | 2011-11-30 | Nabriva Therapeutics AG | Enantiomerically pure amines |
KR20140018286A (en) | 2011-03-18 | 2014-02-12 | 노파르티스 아게 | Combinations of alpha 7 nicotinic acetylcholine receptor activators and mglur5 antagonists for use in dopamine induced dyskinesia in parkinson's disease |
JPWO2013081094A1 (en) * | 2011-11-30 | 2015-04-27 | 東レ株式会社 | Imidazo [1,2-a] pyridine derivative and its pharmaceutical use |
US9365556B2 (en) | 2012-03-16 | 2016-06-14 | Axikin Pharmaceuticals, Inc. | 3,5-diaminopyrazole kinase inhibitors |
US9233961B2 (en) | 2013-03-15 | 2016-01-12 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
US9186361B2 (en) | 2013-03-15 | 2015-11-17 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
CA2917262A1 (en) | 2013-07-02 | 2015-01-08 | Syngenta Participations Ag | Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents |
NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
SG11201604618TA (en) | 2013-12-19 | 2016-07-28 | Novartis Ag | [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis |
EP3180341B1 (en) | 2014-08-12 | 2022-04-27 | Syngenta Participations AG | Pesticidally active heterocyclic derivatives with sulphur containing substituents |
CN107001364B (en) | 2014-12-11 | 2020-06-16 | 先正达参股股份有限公司 | Pesticidally active tetracyclic derivatives with sulfur-containing substituents |
US9546163B2 (en) | 2014-12-23 | 2017-01-17 | Axikin Pharmaceuticals, Inc. | 3,5-diaminopyrazole kinase inhibitors |
US10104893B2 (en) | 2015-04-24 | 2018-10-23 | Syngenta Participations Ag | Pesticidally active polycyclic derivatives with sulfur substituted five membered ring heterocyles |
JP2018513870A (en) | 2015-04-24 | 2018-05-31 | シンジェンタ パーティシペーションズ アーゲー | Pesticide active polycyclic derivatives having sulfur-substituted 5-membered heterocycles |
BR112018000052A2 (en) | 2015-07-01 | 2018-09-04 | Syngenta Participations Ag | pesticide-active polycyclic derivatives with sulfur-containing substituents |
US10745396B2 (en) | 2015-07-01 | 2020-08-18 | Syngenta Participations Ag | Pesticidally active polycyclic derivatives with sulfur containing substituents |
WO2017087905A1 (en) | 2015-11-20 | 2017-05-26 | Denali Therapeutics Inc. | Compound, compositions, and methods |
US10738045B2 (en) | 2015-11-23 | 2020-08-11 | Syngenta Participations Ag | Pesticidally active heterocyclic derivatives with sulphur and cyclopropyl containing substituents |
US11028080B2 (en) | 2016-03-11 | 2021-06-08 | Denali Therapeutics Inc. | Substituted pyrimidines as LRKK2 inhibitors |
CR20220182A (en) | 2016-06-16 | 2022-06-15 | Denali Therapeutics Inc | Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders |
CN109890818B (en) | 2016-10-27 | 2022-11-25 | 先正达参股股份有限公司 | Pesticidally active heterocyclic derivatives with sulphur and hydroxylamine substituents |
WO2018091389A1 (en) | 2016-11-17 | 2018-05-24 | Syngenta Participations Ag | Pesticidally active heterocyclic derivatives with sulphur containing substituents |
US20190308982A1 (en) | 2016-12-15 | 2019-10-10 | Syngenta Participations Ag | Pesticidally active heterocyclic derivatives with sulfur containing substituents |
DK3562487T3 (en) | 2016-12-29 | 2024-01-02 | Ji Xing Pharmaceuticals Hong Kong Ltd | METALLOENZYME INHIBITOR COMPOUNDS |
WO2018125799A2 (en) * | 2016-12-29 | 2018-07-05 | Viamet Pharmaceuticals (Bermuda), Ltd. | Metalloenzyme inhibitor compounds |
BR112019021400A2 (en) | 2017-04-26 | 2020-04-28 | Basilea Pharmaceutica International AG | processes for the preparation of furazanobenzimidazoles and crystalline forms thereof |
WO2018215304A1 (en) | 2017-05-22 | 2018-11-29 | Syngenta Participations Ag | Tetracyclic pyridazine sulphur containing compounds and their use as pesticides |
TW201920146A (en) | 2017-07-05 | 2019-06-01 | 瑞士商先正達合夥公司 | Pesticidally active heterocyclic derivatives with sulfur containing substituents |
MY197923A (en) * | 2018-05-22 | 2023-07-25 | Nihon Nohyaku Co Ltd | Benzimidazole compound or salt thereof, agricultural and horticultural insecticidal and acaricidal agent containing said compound, and method for using same |
AR115495A1 (en) | 2018-06-06 | 2021-01-27 | Syngenta Crop Protection Ag | HETEROCYCLIC DERIVATIVES WITH SUBSTITUENTS CONTAINING ACTIVE SULFUR AS PESTICIDES |
EP3965761A4 (en) * | 2019-03-25 | 2023-06-21 | The Trustees Of Columbia University In The City Of New York | Selective foxo inhibitors for treatment of diabetes and other disorders related to impaired pancreatic function |
TW202104166A (en) * | 2019-04-10 | 2021-02-01 | 瑞士商西萊絲蒂亞生物科技股份有限公司 | Inhibitors of notch signalling pathway and use thereof in treatment of cancers |
AU2022286144A1 (en) * | 2021-06-02 | 2024-01-18 | Nihon Nohyaku Co., Ltd. | Benzimidazole compound or salt thereof, canine filariasis control agent containing same, and method of use thereof |
US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1635890A (en) * | 2000-08-08 | 2005-07-06 | 奥索-麦克尼尔药品公司 | Neuroprotective 2-pyridinamine compositions and related methods |
ES2291455T3 (en) * | 2001-03-12 | 2008-03-01 | Avanir Pharmaceuticals | BENCIMIDAZOL COMPOUNDS TO MODULATE IGE AND INHIBIT THE CELL PROLIFERATION. |
EP1539749A4 (en) * | 2002-09-13 | 2007-06-13 | Merck & Co Inc | Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators |
AU2005215379A1 (en) * | 2004-02-12 | 2005-09-01 | Merck & Co., Inc. | Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
CA2561718A1 (en) * | 2004-04-13 | 2005-10-27 | Icagen, Inc. | Polycyclic pyridines as potassium ion channel modulators |
-
2008
- 2008-04-17 MX MX2009011208A patent/MX2009011208A/en not_active Application Discontinuation
- 2008-04-17 CN CN200880017209A patent/CN101679299A/en active Pending
- 2008-04-17 KR KR1020097024024A patent/KR20090130141A/en not_active Application Discontinuation
- 2008-04-17 BR BRPI0810653-3A2A patent/BRPI0810653A2/en not_active Application Discontinuation
- 2008-04-17 WO PCT/EP2008/054682 patent/WO2008128968A1/en active Application Filing
- 2008-04-17 PE PE2008000666A patent/PE20090074A1/en not_active Application Discontinuation
- 2008-04-17 CA CA002682676A patent/CA2682676A1/en not_active Abandoned
- 2008-04-17 JP JP2010503503A patent/JP2010524892A/en active Pending
- 2008-04-17 AR ARP080101578A patent/AR068072A1/en unknown
- 2008-04-17 EP EP08736339A patent/EP2146969A1/en not_active Withdrawn
- 2008-04-17 EA EA200901379A patent/EA200901379A1/en unknown
- 2008-04-17 AU AU2008240790A patent/AU2008240790A1/en not_active Abandoned
- 2008-04-18 TW TW097114322A patent/TW200904425A/en unknown
- 2008-04-18 US US12/148,557 patent/US20090105266A1/en not_active Abandoned
- 2008-04-18 CL CL2008001114A patent/CL2008001114A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101679299A (en) | 2010-03-24 |
PE20090074A1 (en) | 2009-03-02 |
EP2146969A1 (en) | 2010-01-27 |
KR20090130141A (en) | 2009-12-17 |
JP2010524892A (en) | 2010-07-22 |
CA2682676A1 (en) | 2008-10-30 |
CL2008001114A1 (en) | 2008-12-19 |
EA200901379A1 (en) | 2010-04-30 |
US20090105266A1 (en) | 2009-04-23 |
AU2008240790A1 (en) | 2008-10-30 |
BRPI0810653A2 (en) | 2014-11-04 |
WO2008128968A1 (en) | 2008-10-30 |
AR068072A1 (en) | 2009-11-04 |
TW200904425A (en) | 2009-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009011208A (en) | Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5. | |
TW200732323A (en) | Organic compounds | |
MX2010001338A (en) | Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions. | |
IN2014CN04127A (en) | ||
MX2009013078A (en) | Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842. | |
UA85576C2 (en) | Tetrazole compounds and their use as metabotropic glutamate receptor antagonits | |
TW200604183A (en) | Triazole compounds and their use as metabotropic glutamate receptor antagonists | |
MY169986A (en) | Benzimidazole-proline derivatives | |
MX2011011661A (en) | Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750. | |
MX2009011816A (en) | 2 -pyridine carboxamide derivatives as sodium channel modulators. | |
MY148634A (en) | Pyridazinone derivatives | |
IL189987A0 (en) | Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists | |
EA201001683A1 (en) | Derivatives of phenyl or pyridinyl substituted indazols | |
MY169432A (en) | Bicyclo[3.2.1]octyl amide derivatives and uses of same | |
WO2009024611A3 (en) | 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use | |
MX2010003001A (en) | Quinoline derivatives as 5ht5a receptor antagonists. | |
MY151986A (en) | Adamantyl diamide derivatives and uses of same | |
MX2010009022A (en) | 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use. | |
TW200738653A (en) | Anthranilamide/2-amino-heteroarene carboxamide derivatives | |
RS51661B (en) | Diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them | |
MX2021004000A (en) | Piperidine cxcr7 receptor modulators. | |
MX2009010505A (en) | Pyridine and pyrimidine derivatives as mglur2 antagonists. | |
EA201270428A1 (en) | SUBSTITUTED N-PHENYL-1- (4-PYRIDINIL) -1H-PYRAZOL-3-AMINES | |
MX2012002369A (en) | Anhydrate forms of a pyridine derivative. | |
WO2009050197A3 (en) | Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |